Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Pharma
Novartis' Pluvicto slows progression in earlier prostate cancer
Novartis also reported an early positive trend in overall survival, although that data point remained immature.
Angus Liuu
Oct 19, 2025 10:30am
AZ faces FDA challenge as Imfinzi-Lynparza miss survival goal
Oct 19, 2025 4:15am
ESMO: Datroway data edge out Trodelvy in first TROP2 face-off
Oct 19, 2025 2:30am
ESMO: Enhertu wields 2-fisted power in early breast cancer
Oct 18, 2025 10:30am
FDA approves 2nd indication for Amgen, AstraZeneca's Tezspire
Oct 17, 2025 5:12pm
AZ's Imfinzi looks set up for another bladder cancer expansion
Oct 17, 2025 8:10am
